We need to know what jurisdiction(s) and product type(s) are the subject of your questions. In the meantime, I can give some general opinions.
Specifically, in my opinion, the only sensible and safe KPI target for adverse event reporting is that all (100% of) adverse event reports are submitted on time, all the time. I advise against letting the corporate KPI process and its bells and whistles cause you to get too creative about this. For example, tardy adverse event reports iare an automatic trigger for the U.S. FDA to automatically consider a Warning Letter for some products.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 25-Jan-2024 02:59
From: Anonymous Member
Subject: Targets for Ontime Adverse Event Reporting
This message was posted by a user wishing to remain anonymous
Hi All,
We are in the process of adapting our KPI metrics for adverse event reporting.
1) Can you share any insight you may have to KPI targets for adverse event reporting?
2) What outcomes have you experienced or seen for isolated incidences of missed reporting due dates or for a pattern of missed reporting due dates.
Thank you in advance.